Navigation Links
Sinovac Begins the Production of Influenza A (H1N1) Vaccine
Date:6/8/2009

BEIJING, June 8 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE Amex: SVA), a leading developer and provider of vaccines in China, announced today that it begins the production of a vaccine against influenza A (H1N1) virus. The virus seed was received from US CDC and was delivered to the company on June 8, 2009.

Mr. Weidong Yin, Chairman, President and CEO of Sinovac, commented, ''In the midst of a global outbreak and transmission of H1N1, our mission as a vaccine developer and manufacturer is to protect the public. We are very pleased to offer our expertise in supplying preventative vaccines to the national and local authorities as they focus on controlling the transmission of the H1N1 virus. Today, Sinovac has received the virus seed, we will start the production of H1N1 vaccine immediately from production of virus seed lots. Throughout this critical time, Sinovac will continue its commitment to providing safe and high quality vaccines.''

Sinovac's current annual manufacturing capacity is approximately 20-30 million doses of pandemic influenza vaccine. The capacity for H1N1 will depend on the performance of the virus seed. In order to supply enough vaccines to protect the public within a reasonable period of time, Sinovac and other flu manufactures in China have collaborated to co-manufacture Panflu, Sinovac's pandemic influenza vaccine with H1N1 virus seed upon approval from China's State Food and Drug Administration (SFDA). Sinovac will take the lead, completing key production processes on its own production line, while other flu manufacturers will be producing part of the bulk products and filling and packaging semi-finished products.

Sinovac's internal preparations are being supported by external organizations in order to deliver a high quality vaccine to the market as soon as possible. China'
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2009 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3

Related biology technology :

1. Chinas Vice Premier, Li Keqiang, Visits Sinovac to Inspect H1N1 Vaccine Production Preparation
2. Sinovac to Host Conference Call to Report First Quarter 2009 Financial Results
3. Sinovac Biotech Ltd. Files Annual Report on Form 20-F
4. Sinovac Initiates Preparatory Activities for Swine Flu Vaccine
5. Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables
6. Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results
7. Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2008 Financial Results
8. Sinovac Biotech Co. Ltd., Sinovacs Beijing Subsidiary, Obtains High-Tech Enterprise Status
9. Sinovac Receives GMP Certification for its New Filling and Packaging Production Facility
10. Sinovac Enters Veterinary Vaccine Market with Inactivated Rabies Vaccine
11. Sinovac Releases Statement on Healive Vaccine Suspension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013 Biotechnology industry pioneer ... with financial software provider BlackLine Systems  and enterprise ... SAP ) for a webinar next week entitled "No ... from BlackLine and SAP to Help Keep Its Account Reconciliations ... http://photos.prnewswire.com/prnh/20061117/LAF027LOGO ) The webinar, geared at finance, ...
(Date:6/19/2013)... Canada (PRWEB) June 19, 2013 ... trial business can potentially be worth up to ... this opportunity, the Indian government is taking serious ... trials the process. , This presentation will examine:, ... trial regulations ,     Immediate and long term ...
(Date:6/19/2013)... June 19, 2013 Express Diagnostics Int’l, ... today announced that it has received Class III medical ... sell its DrugCheck® NxStep Onsite Drug Screen Cup ... the rapid screening device in near-patient settings, such as ... Cup received Health Canada Class III approval for 24 ...
(Date:6/18/2013)... A million electric cars could be on roads across ... help of research by the United States Department of Energy, ... Professor Zhongwei Chen is part of a team led by ... to replace the expensive platinum catalysts in fuel cells. , ... cells in vehicles is the cost of the units. The ...
Breaking Biology Technology:Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 2Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 3Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations 4Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3US and Canadian researchers drive towards cheaper fuel cells for electric cars 2
... July 14 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), ... agreement to exclusively license seven cancer antigens from ... antigens specifically target breast, ovarian and prostate cancers. ... DepoVax(TM) delivery platform to develop DPX-0907, a therapeutic ...
... , , TAMPA, Fla., July 14 ... the research and development of cancer immunotherapies, announces that the first ... dendritic cell therapy. , , ... clinical trial testing the safety and efficacy of its immunotherapy on ...
... , , ... biotechnology company delivering breakthrough therapies in central nervous system ... the efficacy of the ketogenic compound AC-1202 (Axona(TM)) in ... completed double-blind, placebo-controlled trial in patients with mild-to-moderate Alzheimer,s ...
Cached Biology Technology:ImmunoVaccine Technologies Licenses Immunotope's Breast, Ovarian and Prostate Cancer Antigens 2Significant Milestone Marks the Beginning of FDA-Authorized Breast Cancer Trial 2Significant Milestone Marks the Beginning of FDA-Authorized Breast Cancer Trial 3Evidence for a New Genetic Link to Therapeutic Efficacy for Alzheimer's Disease 2Evidence for a New Genetic Link to Therapeutic Efficacy for Alzheimer's Disease 3Evidence for a New Genetic Link to Therapeutic Efficacy for Alzheimer's Disease 4
(Date:6/19/2013)... paper published in the journal Polar Biology, researchers report using ... may be a new type of killer whale ( Orcinus ... unusual-looking killer whales stranded on a New Zealand beach and ... were also taken but it was almost 50 years before ... small white eye-patch and bulbous forehead, was documented alive in ...
(Date:6/19/2013)... Insulin is the most potent physiological anabolic agent ... and synthesis of lipids, protein and carbohydrates, and ... system. It also plays a major role in ... glucose is metabolized and removed from the blood ... precise molecular mechanisms by which insulin regulates glucose ...
(Date:6/19/2013)... the Midwest are expected to contribute to a very ... zone," according to a University of Michigan ecologist and ... one for the Chesapeake Bay. , The Gulf forecast, ... Atmospheric Administration, calls for an oxygen-depleted, or hypoxic, region ... place it among the 10 largest on record. , ...
Breaking Biology News(10 mins):Breakthrough research of essential molecule reveals important targets in diabetes and obesity 2U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone' 2U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone' 3U-M researcher and colleagues predict possible record-setting Gulf of Mexico 'dead zone' 4
... plant,s defences and causes disease,by sneakily disabling the plant,s ... (4 December) in Current Biology . ... causes bacterial speck disease,in tomato plants. This bacterial invasion ... cause extensive and costly damage to,tomato crops, and researchers ...
... half of a person,s body mass consisting of skeletal ... those found in the limbs can result in ... kinesiology and community health professor Kimberly Huey, past research ... may be associated with reduced expression of certain pro-inflammatory ...
... earthquakes and destructive tsunamis over the past four years is ... warns an international group of earthquake researchers in their paper ... Nature . , The first of the recent great earthquakes, ... and destructive tsunami in living memory. The cause of ...
Cached Biology News:Red alert! How disease disables tomato plant's 'intruder alarm' 2Vitamin E shows possible promise in easing chronic inflammation 2Vitamin E shows possible promise in easing chronic inflammation 3September 2007 Sumatran earthquakes research findings 2September 2007 Sumatran earthquakes research findings 3
... package is used for determining protein concentration in ... RC DC protein assay is a colorimetric assay. ... assays: 250 ml RC reagent I, 250 ml ... solution, 2 L dilute Folin reagent, and 5 ...
... SureLINK Bioconjugation Kit provides a powerful yet ... and nuceleic acids. The kit provides the ... reagents for quantifying conjugation efficiencies. It enables ... biotin and other tags with a variety ...
...
MAb to HLA, Class II-DR+DP Dry Ice: No Preservative: NaN3 Availability When Not in Inventory: 14-21 Business Days...
Biology Products: